Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colistimethate Sodium for CRE Infection
NCT06051513Recruiting
- Sponsor
- Southeast University
- Start
- Nov 2023
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of colistimethate sodium in Enterobacteriaceae infection (2 arms), sponsored by Southeast University. Primary endpoint: 14-day all cause mortality. Started Nov 2023; status: recruiting.
02
Drugs
colistimethate sodium
03
Conditions
Enterobacteriaceae infection
Beyond the preview
Go deeper on NCT06051513.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06051513.